The nomination period for new positions in the ESCMID Executive Committee, one representing clinical microbiology and two for infectious diseases, closes tonight, 31 August 2021 at 23:59 CEST.
ESCMID encourages you to propose candidates on the ESCMID website.

Be sure to secure your place in the exciting ESCMID online education courses coming up in the coming months. Don’t miss highlights such as ‘Paediatric infection management for the microbiologist, antimicrobial pharmacist and specialist in adult infectious diseases’, taking place from 23 - 24 September 2021.

Don’t miss the next GARDP live webinar, taking place 09:30-11:00 CEST on Wednesday, 8 September 2021. EUCIC Chairperson Evelina Tacconelli (Verona, Italy) will be presenting the topic: ‘Combination antibiotic therapy against drug-resistant Gram-negative bacteria: where the evidence stands’.
Sign up on the GARDP website.

In this study, authors examined the immunogenicity and safety of the BNT162b2 mRNA vaccine in 143 people living with HIV. SARS-CoV-2 receptor binding domain IgG and neutralizing antibodies were measured and adverse events, viral load and CD4 cell counts were monitored. Data suggests that BNT162b2 mRNA vaccine appears immunogenic and safe in PLWH who are on ART with unsuppressed CD4 count and suppressed viral load.